Scientific Advisory Board
Five practising dermatologists from tier-1 Spanish institutions form the founding Scientific Advisory Board, advising Legit.Health on clinical validity, scientific direction, and key opinion leader access. As we enter our priority markets, the board is being extended with international reference dermatologists.
What our advisors say
"Legit.Health's technology is a necessary breakthrough in the world of dermatology. It is not only the best tele-dermatology tool, but also a very useful complement to the face-to-face consultation."
"In the specific case of Hidradenitis Suppurativa, Legit.Health's algorithm helps my entire service to diagnose with greater speed and reliability, even if they are not experts in the pathology."
What the SAB does
Expanding the board into strategic markets
As Legit.Health advances in its priority markets, the board is being extended with reference dermatologists (KOLs) in the countries where we are actively growing: Brazil, the UK, and the US. A local reference does two things at once that a commercial hire cannot: it anchors clinical credibility with regulators and payers, and it opens hospitals and insurers far faster through peer trust.
The expansion is deliberately capital-light: reference dermatologists join on honoraria, not salary.
Track record
- 9 peer-reviewed publications (JAAD, JEADV, JID Innovations, JMIR Dermatology, European Archives of Oto-Rhino-Laryngology, Skin Research & Technology, Skin Health and Disease)
- 6 years of continuous collaboration since 2020